Walgreens Boots Alliance Inc (WBA.OQ)
19 Jan 2018
* WALGREENS BOOTS ALLIANCE INC - BOARD DECLARED A REGULAR QUARTERLY DIVIDEND OF 40 CENTS PER SHARE, AN INCREASE OF 6.7 PERCENT OVER YEAR-AGO PERIOD Source text for Eikon: Further company coverage:
BRIEF-Walgreens Boots Alliance Expects To Obtain Cash Tax Benefit In Excess Of $200 Mln For Fiscal Year 2018, Due To Enacted U.S. Tax Legislation
* WALGREENS BOOTS ALLIANCE - EXPECTS TO OBTAIN CASH TAX BENEFIT IN EXCESS OF $200 MILLION FOR FISCAL YEAR 2018, DUE TO ENACTED U.S. TAX LEGISLATION
* Shares jump as much as 4.7 pct (Adds analyst comments, conference call details; updates shares)
Jan 4 Walgreens Boots Alliance Inc on Thursday reported its sixth straight fall in retail same-store sales in the first quarter of fiscal 2018 along with a drop in gross margins in its U.S. business, sending its shares down as much as 6.3 percent.
Jan 4 Drugstore chain Walgreens Boots Alliance Inc on Thursday reported a 22.1 percent fall in quarterly profit, partly hurt by an impairment charge related to its investment in Chinese wholesale partner Guangzhou Pharmaceuticals.
Jan 3 Drug retailer Rite Aid on Wednesday posted smaller-than-expected quarterly revenue due to a fall in reimbursement rates and a drop in comparable-store sales.
(The following statement was released by the rating agency) NEW YORK, December 22 (Fitch) Fitch Ratings has downgraded GNC Holdings, Inc.'s Issuer Default Rating (IDR) to 'C' from 'B-' following the company's announcement that it will be exchanging approximately $99 million of its $288 million of convertible notes due August 2020 for approximately 14.6 million shares (approximately 17% of pro forma share count or around $55 million in value), given Fitch's view that this represents a distressed
Walgreens Boots Alliance Inc said on Friday it would sell a 30 percent stake in a Chinese pharmaceutical wholesaling joint venture to partner Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd .
Dec 22 Walgreens Boots Alliance Inc said on Friday it would sell a 30 percent stake in a Chinese pharmaceutical wholesaling joint venture to partner Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.
* WALGREENS BOOTS ALLIANCE TO REDUCE STAKE IN GUANGZHOU PHARMACEUTICALS CORPORATION